Fund Name: SBI Pharma (G)
CRISIL Rank: NA
Category: Equity – Sector
Expense Ratio: 3%
Risk Level: High
Benchmark: S&P BSE Healthcare
Objective: To provide the investors maximum growth opportunity through equity investrments in stocks of growth oriented sectors.
SBI Pharma (G) fund has made its inception in the year 2004. Since inception, it has produced annualized returns of 14.91%. It has managed to beat the benchmark index as well as category average comprehensively in the 1, 3 and 5 year returns.
Top 5 holdings of the fund include Sun Pharma, Dr. Reddy’s, Lupin, Divi’s and Glenmark. The returns of this fund ever since inception have been brilliant. If you are interested in the pharmaceutical sector, you can consider investing in it through this fund.